Intelligent Bio Solutions (INBS) Cost of Revenue (2022 - 2024)
Intelligent Bio Solutions has reported Cost of Revenue over the past 3 years, most recently at $645311.0 for Q1 2024.
- Quarterly results put Cost of Revenue at $645311.0 for Q1 2024, up 52.19% from a year ago — trailing twelve months through Mar 2024 was $2.2 million (changed N/A YoY), and the annual figure for FY2023 was $930204.0, changed.
- Cost of Revenue for Q1 2024 was $645311.0 at Intelligent Bio Solutions, up from $564815.0 in the prior quarter.
- Over the last five years, Cost of Revenue for INBS hit a ceiling of $645311.0 in Q1 2024 and a floor of $112635.0 in Q4 2022.
- Median Cost of Revenue over the past 3 years was $493886.0 (2023), compared with a mean of $450682.2.
- Biggest five-year swings in Cost of Revenue: skyrocketed 401.46% in 2023 and later surged 52.19% in 2024.
- Intelligent Bio Solutions' Cost of Revenue stood at $112635.0 in 2022, then skyrocketed by 401.46% to $564815.0 in 2023, then rose by 14.25% to $645311.0 in 2024.
- The last three reported values for Cost of Revenue were $645311.0 (Q1 2024), $564815.0 (Q4 2023), and $563763.0 (Q3 2023) per Business Quant data.